Inventor · disambiguated record
John Paul Watts
Also filed as: WATTS JOHN P · WATTS JOHN PAUL
24 granted patents·10 pending applications·106 citations·filing 1993–2024
94Inventor score
Top patents by PatentIndex Score
34 records- 0192US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 0291US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 0382US5627191ATherapeutic agentsBOOTS CO PLC·Filed 1993·Granted May 6, 1997·32 cites·5 claims
- 0482US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0578US8933109B2Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitorsAMURA THERAPEUTICS LTD·Filed 2013·Granted Jan 13, 2015·3 cites·54 claims
- 0677US7799791B2Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinasesAMURA THERAPEUTICS LTD·Filed 2009·Granted Sep 21, 2010·3 cites·17 claims
- 0777US6114334APiperazine derivatives as therapeutic agentsKNOLL AG·Filed 1996·Granted Sep 5, 2000·47 cites·8 claims
- 0875US7846935B2Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitorsAMURA THERAPEUTICS LTD·Filed 2009·Granted Dec 7, 2010·2 cites·12 claims
- 0975US7803803B2Tetrahydrofuro[3,2-B] pyrrol-3-ones as cathepsin K inhibitorsAMURA THERAPEUTICS LTD·Filed 2009·Granted Sep 28, 2010·2 cites·19 claims
- 1072US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
- 1172US8008290B2CompoundsAMURA THERAPEUTICS LTD·Filed 2010·Granted Aug 30, 2011·3 cites·39 claims
- 1270US2025074900A1Isoindolinone inhibitors of the mdm2-p53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1369US10336702B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2015·Granted Jul 2, 2019·1 cites·28 claims
- 1469US8501744B2Piperazine compoundsQUIBELL MARTIN·Filed 2010·Granted Aug 6, 2013·1 cites·15 claims
- 1568US8389737B2Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitorsQUIBELL MARTIN·Filed 2010·Granted Mar 5, 2013·1 cites·15 claims
- 1663US10766861B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2019·Granted Sep 8, 2020·0 cites·9 claims
- 1763US7737150B2Furo[3, 2-b] pyrrol derivativesAMURA THERAPEUTICS LTD·Filed 2009·Granted Jun 15, 2010·0 cites·14 claims
- 1863US2015164912A1Furo[3, 2-b] pyrr0l-3-ones as cathespin s inhibitorsAMURA THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 1962US6900216B2Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agentsKNOLL GMBH·Filed 2001·Granted May 31, 2005·2 cites·29 claims
- 2062US2021070708A1Pharmaceutically Active CompoundsBERGENBIO ASA·Filed 2020·Application pending·0 cites
- 2159US9045492B2Piperazine compoundsAMURA THERAPEUTICS LTD·Filed 2013·Granted Jun 2, 2015·0 cites·39 claims
- 2259US8552202B2Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitorsAMURA THERAPEUTICS LTD·Filed 2013·Granted Oct 8, 2013·0 cites·31 claims
- 2359US7846934B2Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitorsAMURA THERAPEUTICS LTD·Filed 2009·Granted Dec 7, 2010·0 cites·15 claims
- 2457US2016361295A1Furo[3, 2-b] pyrr0l-3-ones as cathespin s inhibitorsAMURA THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2554US2016015685A1Furo [3, 2-b] pyrr0l-3-0nes as cathespin s inhibitorsAMURA THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 2649US8877927B2Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitorsQUIBELL MARTIN·Filed 2009·Granted Nov 4, 2014·0 cites·27 claims
- 2748US8053437B2Furo[3. 2-B] pyrrol derivativesAMURA THERAPEUTICS LTD·Filed 2010·Granted Nov 8, 2011·0 cites·5 claims
- 2848US8039641B2Tetrahydrofuro[3,2-b] pyrrol-3-one intermediatesAMURA THERAPEUTICS LTD·Filed 2009·Granted Oct 18, 2011·0 cites·6 claims
- 2947US2015209349A1Piperazine CompoundsAMURA THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 3044US2009131502A1Biologically active compoundsQUIBELL MARTIN·Filed 2008·Application pending·0 cites
- 3141US2006100431A1Biologically active compoundsAMURA THERAPEUTICS LTD·Filed 2003·Application pending·0 cites
- 3240US2009005575A1Preparation of diazapentalene derivatives via epoxydation of dihydropyrrolesAMURA THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 3337US10308628B2Heterocyclic compounds and methods for their useNOVARTIS AG·Filed 2016·Granted Jun 4, 2019·0 cites·15 claims
- 3436US10065943B2Pyrrolidine derivatives as angiotensin II type 2 antagonistsNOVARTIS AG·Filed 2016·Granted Sep 4, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when John Paul Watts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →